highly significantp < 0.0001
After 14 days of treatment, the analysis revealed a highly significant ( p < 0.0001) superiority of TBG in the primary efficacy variable. 1.4.
After 14 days of treatment, the analysis revealed a highly significant ( p < 0.0001) superiority of TBG in the primary efficacy variable. 1.4.